Polzer Robert J 4

4 · Zoetis Inc. · Filed Nov 26, 2024

Form 4

Period: 2024-11-25

Executive Vice President

Transactions

Exercise/Conversion
Common Stock
2024-11-25$160.62/sh+1,057$169,775→ 4,306 total
Exercise/Conversion
Common Stock
2024-11-25$162.07/sh+2,420$392,209→ 6,726 total
Sale
Common Stock
2024-11-25$177.46/sh−3,477$617,028→ 3,249 total
Exercise/Conversion
Stock Option
2024-11-25−1,057→ 5,455 total
→ Common Stock (1,057 underlying)
Exercise/Conversion
Stock Option
2024-11-25−2,420→ 4,840 total
Exercise: $162.07→ Common Stock (2,420 underlying)

Holdings

Footnotes (10)

[F1]The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.45 to $177.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F10]One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 6, 2024.
[F2]Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of September 30, 2024.
[F3]Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
[F4]1,057 options granted February 10, 2021 at an exercise price of $160.62 per option.
[F5]Each option vests on the third anniversary of the date of grant.
[F6]Each option expires on the tenth anniversary of the date of grant.
[F7]5,455 options granted February 8, 2022 at an exercise price of $201.30 per option.
[F8]Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
[F9]One-third of each option vests on the first, second and third anniversaries of the date of grant, February 8, 2023.

Documents

1 file